Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

California fires illuminate trauma and resilience

Dorothy Hammack had planned to wash her thick, dark hair in the kitchen sink Friday morning. She couldn't yet shower, due to the incision on her breast from a biopsy a few days before. Her doctor had already called to let her know the results: She had breast cancer.

29 Oct 2019

Patterns of Alzheimer's-related damage differ by subtype and age of onset, study finds

Despite decades of scientific scrutiny, Alzheimer's disease researchers have yet to work out its cause or treatment. Understanding what underlies its three distinct subtypes is thought to be a promising new research avenue.

29 Oct 2019

KAUST researchers one step closer to understanding brain function

Researchers at King Abdullah University of Science and Technology (KAUST) are officially one-step closer to understanding the brain and its function.

29 Oct 2019

Wisconsin study: 3 in 5 people with Down syndrome diagnosed with dementia by age 55

Not so many years ago, people with Down syndrome rarely survived to middle age. Many died young due to heart problems associated with the congenital condition.

29 Oct 2019

Gait disorders can help predict future cognitive decline

The way people walk is an indicator of how much their brains, as well as their bodies, are aging. Scientists reporting in a special supplement to the Journal of Alzheimer's Disease say that gait disorders, particularly slowing gait, should be considered a marker of future cognitive decline.

28 Oct 2019

Older people with Down syndrome at higher risk for Alzheimer's disease, dementia

A study of Wisconsin Medicaid enrollees with Down syndrome has found that more than half of those ages 55 and older have filed at least three claims for dementia and nearly a third have filed at least three claims for Alzheimer's disease.

28 Oct 2019

Study finds heightened risk of adverse financial outcomes prior to Alzheimer's diagnosis

Prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes - a likely consequence of compromised decision making when managing money, in addition to exploitation and fraud by others.

25 Oct 2019

Mayo Clinic study explores patient privacy in MRI research

Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.

24 Oct 2019

Detecting neurotransmitters at the lowest concentrations

Dopamine, serotonin, adrenalin... The smooth functioning of the human brain depends on their correct proportions. Any disturbances mean diseases.

24 Oct 2019

Researchers receive $9.7 million NIH grant to study TBI and neurodegenerative diseases

An international team of experts led by researchers in the Perelman School of Medicine at the University of Pennsylvania and University of Glasgow has been awarded a $9.7 million, five-year grant from the National Institute of Neurological Disorders and Stroke and National Institute for Aging to establish CONNECT-TBI--a program spanning 12 institutions which will study traumatic brain injury and related neurodegenerative diseases.

24 Oct 2019

New NPO formed to accelerate development of therapies for Shankopathies

Parents of children affected by Phelan-McDermid syndrome (PMS) announce the formation of CureSHANK, a nonprofit organization on a mission to accelerate drug development in PMS and other diseases related to the SHANK genes for which there are currently no FDA approved treatments.

23 Oct 2019

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.

23 Oct 2019

Discovery sheds light on TNFα protein's role in impairing memory in Alzheimer's disease

Otago scientists have made an important discovery in understanding the role a particular protein plays to impair memory in Alzheimer's disease, which could lead to more effective treatment in future.

23 Oct 2019

UCLA-led study finds brain injury as cause of dementia in some older adults

A UCLA-led study finds that, with the use of MRI scans, it is possible to distinguish between memory loss caused by Alzheimer's disease and traumatic brain injury.

23 Oct 2019

Dementia patients’ adult kids develop symptoms six years earlier than their parents

A person's chance of developing dementia is influenced by family history, variations in certain genes, and medical conditions such as cardiovascular disease and diabetes. But less is known about the factors that affect when the first symptoms of forgetfulness and confusion will arise.

22 Oct 2019

More brain pathology and hospitalizations associated with faster rate of cognitive decline

Older people who experienced more hospitalizations and also had more Alzheimer's pathology in their brain experienced the fastest rates of cognitive decline, according to study results published in the October 15 online issue of the Annals of Neurology.

22 Oct 2019

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Mount Sinai researchers have been awarded a $3.2 million grant from the National Institutes of Health to pursue a deeper understanding of Down syndrome, the most common genetic cause of intellectual and developmental disabilities in children and young adults, affecting more than 200,000 individuals in the United States.

22 Oct 2019

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.

22 Oct 2019

Study to examine whether cancer and co-occurring Alzheimer's alter pain perception

A new multisite study funded by the National Institute on Aging will examine whether co-occurring Alzheimer's disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

21 Oct 2019

Salk Institute scientists receive NIH grant to better understand the brain

Salk Institute scientists Nicola Allen, Eiman Azim, Margarita Behrens, and Joseph Ecker have been named recipients in the 2019 round of grants from the National Institutes of Health (NIH) to better understand the brain.

21 Oct 2019

Alzheimer's Disease News and Research

Further Reading

California fires illuminate trauma and resilience

Patterns of Alzheimer's-related damage differ by subtype and age of onset, study finds

KAUST researchers one step closer to understanding brain function

Wisconsin study: 3 in 5 people with Down syndrome diagnosed with dementia by age 55

Gait disorders can help predict future cognitive decline

Older people with Down syndrome at higher risk for Alzheimer's disease, dementia

Study finds heightened risk of adverse financial outcomes prior to Alzheimer's diagnosis

Mayo Clinic study explores patient privacy in MRI research

Detecting neurotransmitters at the lowest concentrations

Researchers receive $9.7 million NIH grant to study TBI and neurodegenerative diseases

New NPO formed to accelerate development of therapies for Shankopathies

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Discovery sheds light on TNFα protein's role in impairing memory in Alzheimer's disease

UCLA-led study finds brain injury as cause of dementia in some older adults

Dementia patients’ adult kids develop symptoms six years earlier than their parents

More brain pathology and hospitalizations associated with faster rate of cognitive decline

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Study to examine whether cancer and co-occurring Alzheimer's alter pain perception

Salk Institute scientists receive NIH grant to better understand the brain

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News